ACTIVE

Horus Pharma Belux

Export PDF

Financial year 2024 · Closed on 31/12/2024

Net result161,7 k €+52,4 %over 1 year
Gross margin1,9 M €+13,8 %over 1 year
Equity-3,2 M €+4,8 %over 1 year
Workforce13,0 ETP-7,1 %over 1 year

Identity

Source · BCE/KBO

Horus Pharma Belux is a Public limited company incorporated in 2015. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Anderlecht. It employs on average 13,0 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0633.793.446
Incorporation
13/07/2015
Legal form
Public limited company
Registered office
Route de Lennik 451
1070 Anderlecht · BruxellesSee on map
Contributed capital
300 000,00 €
Latest accounts
31/12/2024
Average workforce
13,0 ETP
Joint committees (1)
  • 200
Signals
ProfitablePositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 9 filings

Trend over 9 financial years

20242023202220212020
Income statement
Gross margin1,9 M €1,7 M €1,4 M €1 M €931,3 k €
EBITDA250,4 k €199,7 k €231,9 k €119,3 k €100,2 k €
Operating result241,7 k €196,1 k €126 k €133,3 k €94,2 k €
Net result161,7 k €106,1 k €52,5 k €67,1 k €38,1 k €
Balance sheet
Equity-3,2 M €-3,4 M €-3,5 M €-3,5 M €-3,6 M €
Total assets3,3 M €3,3 M €3,5 M €3,1 M €2,6 M €
Cash122 k €103,3 k €150,8 k €103,9 k €66,7 k €
Debts6,5 M €6,6 M €6,9 M €6,6 M €6,1 M €
Other
Workforce13,0 ETP14,0 ETP14,0 ETP9,3 ETP6,4 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2024

2 active · 4 ended

Active mandates

CLARET CLAUDE

Director · since 09 juillet 2021 · until 08 juillet 2027

Active
HORUS PHARMA SAS

Director · since 22 juin 2018 · until 21 juin 2024

Active

Ended mandates

CLARET CLAUDE

Director · since 09 juillet 2015 · until 08 juillet 2021

Ended
Edel Pharma

Director · since 09 juillet 2015 · until 08 juillet 2021 · 0633.527.487

Ended
HORUS PHARMA SAS

Director · since 09 juillet 2015 · until 08 juillet 2021

Ended
KOEN ZANG

Director · since 09 juillet 2015 · until 08 juillet 2021

Ended

Other companies at this address

Route de Lennik 451 1070 Anderlecht
CompanyCBE no.
ADVIES ADMINISTRATIE EN BEDRIJVENCENTRUM● Active
0472.494.027
AeroVia● Active
1027.808.634
AKL TRANSPORT● Active
1006.451.115
A.VANLOOCK● Active
0678.977.036
B.C.T. ET PARTNERS● Active
0454.249.614
Beheers- en belangenvennootschap voor Audiovisuele Producten - B.A.V.P. Cable● Active
0456.222.078
BE-ISAN● Active
0506.956.147
BeMeSo● Active
0687.998.036
CedricFM● Active
0707.790.588
CEGEDIM BELGIUM● Active
0444.018.488
CROSSLAW● Active
0712.773.123
DEBCA● Active
0480.189.788
DEBROUX 15A/B● Active
0887.316.210
ECE● Active
0807.097.012
EFFIK BENELUX● Active
0838.111.078
EUROPEAN MEDICAL BONE BANK● Active
0632.568.672
Exact● Active
0809.627.425
Ferring● Active
0428.038.135
FISCHBEIN● Active
0401.889.806
Gm Detailling● Active
1019.764.166

Full financial information

Source · NBB
202420232022202120202019
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202401/01/202301/01/202201/01/202101/01/202001/01/2019
Closing of the financial year31/12/202431/12/202331/12/202231/12/202131/12/202031/12/2019
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date01/08/202513/08/202427/08/202327/07/202223/08/202124/09/2020
General meeting26/06/202527/06/202413/06/202330/06/202224/06/202131/03/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 9 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202426/06/202501/08/2025FrenchPDF
Abridged model31/12/202327/06/202413/08/2024FrenchPDF
Abridged model31/12/202213/06/202327/08/2023FrenchPDF
Abridged model31/12/202130/06/202227/07/2022FrenchPDF
Abridged model31/12/202024/06/202123/08/2021FrenchPDF
Abridged model31/12/201931/03/202024/09/2020FrenchPDF
Abridged model31/12/201827/06/201928/08/2019FrenchPDF
Abridged model31/12/201722/06/201828/06/2018FrenchPDF
Abridged model31/12/201629/06/201713/09/2017FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

2 active · 4 ended

Active mandates

CLARET CLAUDE

Director · since 09 juillet 2021 · until 08 juillet 2027

Active
HORUS PHARMA SAS

Director · since 22 juin 2018 · until 21 juin 2024

Active

Ended mandates

CLARET CLAUDE

Director · since 09 juillet 2015 · until 08 juillet 2021

Ended
Edel Pharma

Director · since 09 juillet 2015 · until 08 juillet 2021 · 0633.527.487

Ended
HORUS PHARMA SAS

Director · since 09 juillet 2015 · until 08 juillet 2021

Ended
KOEN ZANG

Director · since 09 juillet 2015 · until 08 juillet 2021

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates25/11/2025
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - DEMISSIONS, NOMINATIONS
    PDF
  • Other28/02/2024
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates08/07/2022
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates02/12/2020
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates29/10/2020
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates13/07/2018
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates11/07/2018
    DENOMINATION
    PDF
  • Mandates22/09/2017
    DEMISSIONS, NOMINATIONS
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 2024161,7 k €↑
  2. 2023
    Annual accounts 2023106,1 k €↑
  3. 2022
    Annual accounts 202252,5 k €↓
  4. 2022
    Name changeHORUS PHARMA BELUX
  5. 2021
    Annual accounts 202167,1 k €↑
  6. 2021
    Name changeHORUS PHARMA BENELUX SA
  7. 2020
    Annual accounts 202038,1 k €↑
  8. 2019
    Annual accounts 2019-570,6 k €↑
  9. 2018
    Annual accounts 2018-658,1 k €↑
  10. 2017
    Annual accounts 2017-1,3 M €↑
  11. 2016
    Annual accounts 2016-1,4 M €
  12. 13/07/2015
    IncorporationPublic limited company